Therapeutic treatment for inhibiting vascular restenosis

Details Therapeutic treatment for inhibiting vascular restenosis Therapeutic treatment for inhibiting vascular restenosis

1994-05-27

1996-11-05

Rories, Charles C. P.

Chemistry: molecular biology and microbiology

Spore forming or isolating process

536 245, 536 2431, 536 2433, 536 261, C12N 510, C12N 508, C07H 2104, C07H 2102

Patent

active

055717136

ABSTRACT:
A composition suitable for administration to a warm-blooded animal comprising antisense MCP-1 peptide or oligonucleotide or a molecule capable of interacting with MCP-1 peptide or information for its synthesis which may or may not be labeled with a radionuclide by means of a chelate ligand capable of administration to an animal to produce reliable visual imaging of areas of potential restenosis or to produce therapeutic effects on areas of areas of potential restenosis.

REFERENCES:
patent: 4276280 (1981-06-01), Akerkar et al.
patent: 4520112 (1985-05-01), Snyder et al.
patent: 4656280 (1987-04-01), Garlick
patent: 4659839 (1987-04-01), Nicolotti et al.
patent: 4732974 (1988-03-01), Nicolotti et al.
patent: 4832940 (1989-05-01), Ege
patent: 4837003 (1989-06-01), Nicolotti
patent: 4926869 (1990-05-01), Rubin et al.
patent: 4965392 (1990-10-01), Fritzberg et al.
patent: 4986979 (1991-01-01), Morgan, Jr. et al.
patent: 5037630 (1991-08-01), Fritzberg et al.
patent: 5079228 (1992-01-01), Cohen et al.
patent: 5120525 (1992-06-01), Goldenberg
patent: 5179078 (1993-01-01), Rollins et al.
patent: 5196510 (1993-03-01), Rodwell et al.
patent: 5198424 (1993-03-01), McEver
patent: 5225180 (1993-07-01), Dean et al.
patent: 5241049 (1993-08-01), Goodman et al.
J. Wang et al., "Human Recombinant Macrophage Inflammatory Protein-1.alpha. and -.beta. and Monocyte . . . ", J. Immunol., vol., 150, No. 7, pp. 3022-3029, (Apr. 1, 1993).
A. K. Samanta et al., "Interleukin 8 (Monocyte-derived Neutrophil Chemotactic Factor) . . . ", J. Biol. & Chem., vol. 285, No. 1, pp. 183-189, (Jan. 6, 1990).
Schitzel, W., et al., "Neutorphil Activating Peptide-2 Binds with Two Affinities to . . . ", Biochem. & Biophys. Res. Comm., vol. 1, No. 1, pp. 301-307, (Oct. 15, 1991).
Horuk, R., et al., "Purification, Receptor Binding Analysis . . . ", Journ. Biolog. Chem., vol. 268, No. 1, pp. 541-546 (Jan. 5, 1993).
Neote, K., et al., "Identification of a Promiscuous Inflammatory . . . ", Journ. Biolog. Chem., vol. 268, No. 17, pp. 12247-12249, (Jun. 15, 1993).
Besemer, J., et al., "Specific Binding, Internalization, and Degredation of Human . . . ", Journ. Biolog. Chem., vol. 264, No. 29, pp. 17409-17415, (Oct. 15, 1989).
Elner, V. M., et al., "Rapid Communication . . . ", Amer. Journ. Pathol., vol. 136, No. 4, pp. 745-750, (Apr. 1990).
Standiford, T. J., et al., "Disparate Regulation of Interleukin 8 Gene Expression From Blood . . . ", Biochem. & Biophys. Res. Comm., vol. 171, No. 2, pp. 531-536, (Sep. 14, 1990).
Thornton, A. J., et al., "Cytokine-Induced Gene Expression . . . ", J. Immuno., vol. 144, No. 7, pp. 2609-2613, (Apr. 1, 1990).
Samanta, A. K., et al., "Identification and Characterization of Specific Receptors for . . . ", J. Exper. Med., vol. 169, pp. 1185-1189, (Mar. 1989).
Hebert, C. A., et al., "Endothelial and Leukocyte Forms of IL-8 . . . ", J. Immuno., vol. 145, No. 9, pp. 3033-3040, (Nov. 1, 1990).
Darbonne, W. C., et al., "Red Blood Cells Are a Sink for Interleukin 8, a Leukocyte Chemotaxin", J. Clin. Invest., vol. 88, pp. 1362-1369, (Oct. 1991).
Ross, R., "Medical Progress: The Pathogenesis of Atherosclerosis . . . ", New Eng. J. of Med., vol. 314, No. 8, pp. 488-500, (Feb. 20, 1986).
Grob, P. M., et al., "Characterization of a Receptor for Human Monocyte-derived . . . ", J. Biolog. Chem., vol. 265, No. 14, pp. 8311-8316, (May 15, 1990).
Clark-Lewis, I., et al., "Platelet factor 4 binds to interleukin 8 . . . ", Proc. Natl. Acad. Sci., vol. 90, pp. 3574-3577, (Apr. 1993).
Rot. Antal, "Binding of Neutrophil Attractant/Activation Protein-1 . . . ", Chemical Abstracts, vol. 119, No. 21, (Nov. 22, 1993) and Cytokine, vol. 4, No. 5, pp. 347-352, (1992). Abstract.
Vita, N., et al., "Functional Linkage of the Gro.Beta and IL-8 Receptors on the Surface . . . ", Chemical Abstracts, vol. 120, No. 9, and Eur. Cytokine Network, vol. 4, No. 3, pp. 197-204, (1993). Abstract.
Uhlmann, E. et al. "Antisense Oligonucleotides: A New Therapeutic Principle" Chemical Reviews 90(4) 543-584 (Jun. 1990).
Souza, S. J. U. and Bretani, R. J., Biol. Chem. 267:13763-13773 (1992).

Affiliated with

Also associated with

Rating

Therapeutic treatment for inhibiting vascular restenosis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic treatment for inhibiting vascular restenosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic treatment for inhibiting vascular restenosis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2014423